Supplementary Figure S1 from Mechanisms of Response and Tolerance to Active RAS Inhibition in <i>KRAS</i>-Mutant Non–Small Cell Lung Cancer

作者：Haniel A. Araújo, Ximo Pechuan-Jorge, Teng Zhou, Minh Truong, Xin Hu, Frank Rojas, Maria E. Salvatierra, Heladio P. Ibarguen, Richard Lee, Rashi Raghulan, Harshit Shah, Mariela A. Moreno Ayala, Kevin Chen, Nataliya Tovbis Shifrin, Shuhong Wu, Luisa M. Solis Soto, Marcelo V. Negrão, Don L. Gibbons, David S. Hong, Jack A. Roth, John V. Heymach, Jianjun Zhang, Jingjing Jiang, Mallika Singh, Jacqueline A.M. Smith, Elsa Quintana, Ferdinandos Skoulidis · 年份：2026 · DOI：10.1158/2159-8290.32700010 · 研究领域：Protein Kinase Regulation and GTPase Signaling、PI3K/AKT/mTOR signaling in cancer、HER2/EGFR in Cancer Research

<p>Supplementary Figure S1. Activity of RAS inhibitors in immune-competent pre-clinical models of KRASG12C-mutated NSCLC.</p>